Navigation Links
Intel Co-Founder Andrew S. Grove Dedicates Portion of His Estate, Up to $40 Million, to Michael J. Fox Foundation
Date:1/10/2008

Founding Gift for "The Grove Circle," Honoring Planned Gift Donors, Reflects Shared Commitment to Transformative Approach

NEW YORK, Jan. 10 /PRNewswire-USNewswire/ --- Andrew S. Grove, co-founder of technology giant Intel and senior advisor to The Michael J. Fox Foundation for Parkinson's Research, announced his intent to bequeath a portion of his estate, up to $40 million, to The Michael J. Fox Foundation. Mr. Grove's gift will establish The Grove Circle, a society to honor those who provide for the Foundation through their wills or other planned gifts.

"Andy Grove's gift is not only an incredible vote of confidence in MJFF, but will also have a dramatic impact on MJFF's ability to fund paradigm-shifting PD research," said Katie Hood, CEO of The Michael J. Fox Foundation. "Andy's generosity, and his leadership in establishing The Grove Circle for planned gifts, will further strengthen our longtime partnership in pursuing our common goal -- to do whatever it takes, including driving change of a flawed system, to speed delivery of transformative treatments and a cure for Parkinson's disease."

"Despite decades of research, we have no known cure for any neurodegenerative disease today," said Mr. Grove. "Coming up with new treatments may require creative and even unorthodox approaches. Every interaction I've had with The Michael J. Fox Foundation over the years has demonstrated their willingness to go where others may hesitate. There is no one I trust more than the Foundation's leadership and staff to direct my contribution effectively."

Mr. Grove specifically pointed to the Foundation's progress in building an in-house scientific team that actively injects itself into the research process, drives collaboration between academic and industry researchers and, increasingly, targets funding to identify and advance the most promising therapeutic targets for PD.

Mr. Grove has worked with MJFF's leadership since May 2001. He took on the role of Senior Advisor to the Foundation in January 2006. Following his diagnoses of prostate cancer in 1995 and Parkinson's disease in 2000, his has become a major voice calling for a "cultural revolution" in biomedical research to speed the delivery of cures. In November 2007 he spoke at the annual meeting of the Society for Neuroscience, arguing that finding new treatments for disease requires different attitudes toward failed experiments and a major rebalancing of research spending.

Mr. Grove's gift will provide a further boost to MJFF's momentum by establishing The Grove Circle, a new planned giving society honoring the Foundation's many friends who plan their estates to support The Michael J. Fox Foundation after their families' needs have been met. More information on The Grove Circle, including benefits of membership and how to become a charter member, is available at http://www.michaeljfox.org.

Deborah W. Brooks, co-founder of MJFF, commented, "The Michael J. Fox Foundation's mission has always been to put itself out of business by curing PD. Needless to say, this key Foundation value is not changing with the establishment of a planned giving effort. Rather, the planned giving established by The Grove Circle's members will provide a major, long-term funding source around which we can plan and which we can leverage immediately to accelerate groundbreaking research."

Founder Michael J. Fox concluded: "Andy has been an incredible benefactor to our Foundation throughout our years of working together. Leave it to him to find one more way to maximize the impact of his generosity and foresight on behalf of PD patients everywhere."

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. The Foundation has funded $110 million in research to date.


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. National Drug Intelligence Center Releases 2008 National Methamphetamine Threat Assessment
2. Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc.
3. StemCor Systems Announces Acquisition of Intellectual Property to Enhance Bone Marrow Aspiration Platform
4. Written Statement of Kevin J. OConnor, Chairman of the Department of Justice Task Force on Intellectual Property, at the Senate Judiciary Committee Hearing on Intellectual Property Enforcement
5. Emotional Intelligence and the use of tobacco and cannabis
6. Therap Services to Attend 2nd International Conference on Intellectual Disabilities/Mental Retardation as Gold Sponsor
7. Cogon Systems Supports the Pensacola Bay Area Chamber of Commerce with the Strategic Health Intelligence Summit
8. IntelliPharmaCeuitics Ltd. Announces Generic Drug Commercialization Activities
9. NDMA Launches Clinical Intelligence Platform
10. Turn Competitive Intelligence into a Competitive Edge
11. Depression can foreshadow intellectual decline in older people
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... ... not your typical author. She went from working as a movie extra on Bill Murray’s ... she isn’t swimming as a performing mermaid. , Her book isn’t typical either. In Carothers’ ... comedic look at the dysfunctions of God’s family, before Lucifer was sent to hell. ...
(Date:2/27/2017)... ... February 27, 2017 , ... Texas based retail ... addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds 150,000. , ... had 800 customers and 2,250 RCEs at the time of acquisition. In the ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is ... Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads ... founder of IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the ...
(Date:2/25/2017)... ... ... FCPX users now have the ability to sharpen a desired color range ... have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, and ... can visually see the color range effected with ease all within Final Cut ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a ... diagnostic tests and pathology services, announced today the acceptance ... United States and Canadian Academy ... in San Antonio, Texas . ... from the Company,s extensive experience in molecular thyroid testing, ...
(Date:2/27/2017)... 27, 2017  International Biophysics Corporation, a global medical device ... announced a 34% revenue growth in 2016 when compared to ... sales.  This growth was fueled by its AffloVest® sales in ... the expansion of its global sales of surgical product lines. ... "As we enter our 25 th year in delivering ...
(Date:2/27/2017)... 2017   Vitasome ® Labs , Inc. ... its groundbreaking new liposome technology. Whereas vitamins lose on ... digestion per Physician,s Desk Reference , Vitasome , ... nutritional waste and are scientifically formulated to: ... Improve bioavailability with a vastly higher absorption ...
Breaking Medicine Technology: